Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study.
Trněný M, Avigdor A, McKinney MS, Paneesha S, Wahlin BE, Hrom JS, Cunningham D, Morley N, Canales M, Bastos-Oreiro M, Belada D, Devizzi L, Zheng F, DeMarini DJ, Jiang W, Jiang P, Lynch RC. Trněný M, et al. Among authors: morley n. EClinicalMedicine. 2023 Aug 18;63:102130. doi: 10.1016/j.eclinm.2023.102130. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37662520 Free PMC article.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Munir T, Cairns DA, Bloor A, Allsup D, Cwynarski K, Pettitt A, Paneesha S, Fox CP, Eyre TA, Forconi F, Elmusharaf N, Kennedy B, Gribben J, Pemberton N, Sheehy O, Preston G, Schuh A, Walewska R, Duley L, Howard D, Hockaday A, Jackson S, Greatorex N, Girvan S, Bell S, Brown JM, Webster N, Dalal S, de Tute R, Rawstron A, Patten PEM, Hillmen P; National Cancer Research Institute Chronic Lymphocytic Leukemia Subgroup. Munir T, et al. N Engl J Med. 2024 Jan 25;390(4):326-337. doi: 10.1056/NEJMoa2310063. Epub 2023 Dec 10. N Engl J Med. 2024. PMID: 38078508 Clinical Trial.
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia.
Patel B, Kirkwood AA, Rowntree CJ, Alapi KZ, Barretta E, Clifton-Hadley L, Creasey T, Lee S, Marks DI, Moorman AV, Morley N, Patrick P, Rana Z, Rijneveld A, Snowden JA, Fielding AK. Patel B, et al. Among authors: morley n. Hemasphere. 2024 Jun 6;8(6):e88. doi: 10.1002/hem3.88. eCollection 2024 Jun. Hemasphere. 2024. PMID: 38846719 Free PMC article. No abstract available.
Average Temperature as a Marker of Lymphoma-Associated HLH.
Clark C, Goddard J, Tattersall R, Morley N. Clark C, et al. Among authors: morley n. Clin Lymphoma Myeloma Leuk. 2024 Jul;24(7):455-458.e1. doi: 10.1016/j.clml.2024.02.016. Epub 2024 Mar 11. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38582667 Free article.
In Silico Assessment of Biomolecule Reactivity with Leachables.
Johnson C, Kiehl D, Christiaens P, Jodar FS, Cuyvers R, Bassan A, Beilke L, Bercu JP, Costelloe T, Cross KP, Feilden A, Filler R, Lucas MF, Masuda-Herrera MJ, Moghimi M, Morley N, Paskiet D, Pavan M, Pletz J, Reddy MV, Waine CJ, Myatt GJ. Johnson C, et al. Among authors: morley n. PDA J Pharm Sci Technol. 2024 Jun 28;78(3):214-236. doi: 10.5731/pdajpst.2022.012818. PDA J Pharm Sci Technol. 2024. PMID: 38942477
Get2PrEP2-A Provider Messaging Strategy to Improve PrEP Uptake: A Randomized Controlled Quality Improvement Project.
Zucker J, Castor D, Theodore D, Carnevale C, Osilama E, Archer N, Bonadonna L, Wadden E, Morley N, Huang S, Meyers K, Cohall A, Gordon P, Sobieszczyk ME. Zucker J, et al. Among authors: morley n. Open Forum Infect Dis. 2024 Jun 20;11(6):ofae297. doi: 10.1093/ofid/ofae297. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38911948 Free PMC article. Clinical Trial.
189 results